Can-Fite Biopharma (CANF) Return on Assets (ROA) (2011 - 2025)
Can-Fite Biopharma (CANF) Return on Assets (ROA) from Sep 30, 2011 to Jun 30, 2025. The TTM Can-Fite Biopharma (CANF) Return on Assets (ROA) is -25.63%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROA
Quarterly ROA
Annual Return on Assets (ROA) change of Can-Fite Biopharma (CANF)
| Year | Return on Assets (ROA) | Change |
|---|---|---|
| 2025 | -104.21% | +20.60% |
| 2024 | -86.40% | +13.13% |
| 2023 | -76.38% | -30.78% |
| 2022 | -110.34% | +77.48% |
| 2021 | -62.17% | -59.01% |
| 2020 | -151.68% | -1.80% |
| 2019 | -154.47% | +86.91% |
| 2018 | -82.64% | +30.20% |
| 2017 | -63.47% | -6.45% |
| 2016 | -67.85% | +148.77% |
| 2015 | -27.27% | -54.44% |
| 2014 | -59.86% | -52.41% |
| 2013 | -125.79% | -62.96% |
| 2012 | -339.63% | +148.39% |
| 2011 | -136.73% | N/A |